top of page

Continuing Education Webinar: Cancer Detection & Differentiation in Companion Animals

Wed, Mar 04

|

https://us06web.zoom.us/j/87958213550

Discover how the immune system can reveal cancer earlier - often before a tumor appears. Join Dr. Khris Agassandian as he explores serum onconeural antibody testing - the latest advancement in veterinary diagnostics to detect, and differentiate, 22 cancers in companion animals.

Registration is closed
See other events
Continuing Education Webinar: Cancer Detection & Differentiation in Companion Animals
Continuing Education Webinar: Cancer Detection & Differentiation in Companion Animals

Time & Location

Mar 04, 2026, 12:00 PM – 1:00 PM EST

https://us06web.zoom.us/j/87958213550

Guests

About the event

Stay ahead of disease progression with cutting-edge diagnostics designed to support earlier, more confident clinical decisions. 


In this course, Dr. Agassandian explores the science of tumor–immune interactions and the clinical significance of serum onconeural antibodies in companion animals. Participants will examine how these antibodies function as early biomarkers of cancer, assist in differentiating paraneoplastic neurological syndromes, and support diagnostic clarification when cancer is suspected.

Through practical case examples, attendees will learn how to interpret test results and apply onconeural antibody testing in practice — including its role in treatment monitoring and assessing therapeutic response over time.


Registration is FREE and open to all interested veterinary professionals.

*Please Note* This RACE-Approved, live course awards 1 CE credit to Veterinarians and Licensed Technicians.


The founder and CEO of Pet Preferred Diagnostics, Dr. Agassandian is a DVM with a PhD in Neurobiology and Neuroscience whose distinguished career bridges both academic research and diagnostic innovation.
The founder and CEO of Pet Preferred Diagnostics, Dr. Agassandian is a DVM with a PhD in Neurobiology and Neuroscience whose distinguished career bridges both academic research and diagnostic innovation.

Share this event

bottom of page